News

Dr. Harrington, a cardiologist and chair of the Department of Medicine at Stanford University, will begin his new position on Sept. 12.

Awards, honors, prizes and achievements for the month of May. 

Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions.

Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes.

Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.

More than 350 expected graduates – 104 medical doctors, 86 with doctorates and 190 with Master of Science degrees – in the Class of 2023 received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony at Carnegie Hall on May 18.

Weill Cornell Medicine faculty members were honored with awards for their exemplary achievements in medical research, education and care May 17-18 during Weill Cornell Medicine’s commencement activities.

Dr. Cheryl Dreyfus, a distinguished professor and chair of the Department of Neuroscience and Cell Biology at Rutgers-Robert Wood Johnson Medical School, has been awarded the 2023 Weill Cornell Graduate School Alumni Award of Distinction.

Medical students received special awards, prizes and certificates, acknowledging their exceptional academic achievement, scholarship, research, teaching and service. 

Dr. Margaret “Peggy” Bia, M.D. ’72, professor emeritus of internal medicine at Yale School of Medicine, has been awarded the Weill Cornell Medical College Alumni Association Award of Distinction.

Weill Cornell Graduate School of Medical Sciences honored students in the Class of 2023 for their academic achievements.

Dr. David Simon, the Fernholz Foundation Research Scholar in Neuroscience and an assistant professor of biochemistry at Weill Cornell Medicine, was awarded the 2023 Pershing Square Sohn Prize for Young Investigators in Cancer Research on May 16.

The Class of 2023 comprises 23 women and 19 men from 13 countries, including 12 Qatari nationals, and brings the total of doctors educated at WCM-Q to 546 since its inaugural graduation ceremony in 2008.

A scholarship program Weill Cornell Medicine created in 2019 reduces medical education debt for students with financial need, freeing them up to take full advantage of medical school, while pursuing a path in medicine based on their passions and interests. The program covers tuition, fees, housing and living expenses.

Weill Cornell Medicine has received a grant from the National Institutes of Health (NIH) as part of a new $140 million Common Fund program to study somatic mosaicism, a phenomenon in which organs and tissues develop significant genetic differences across their cell populations.

On May 5, Rubin was one of the 47 students in the Class of 2025 to receive their short white coats, gathered before an audience of faculty, family and friends at Griffis Faculty Club as part of the annual white coat ceremony.

Dr. James C. Lo, an associate professor of medicine and Dr. Lisa G. Roth, an associate professor of pediatrics, both from Weill Cornell Medicine, were elected members of the American Society for Clinical Investigation (ASCI) for 2023.

Dr. Tobias Meyer, the Joseph C. Hinsey Professor in Cell and Developmental Biology at Weill Cornell Medicine, has been elected to the American Academy of Arts and Sciences.

Two highly similar molecules with essential, but often contrasting, signaling roles in most life forms exert their distinct effects through subtle differences in their bindings to their signaling partners.

While the peak of the COVID-19 pandemic seems to have passed, the effects of post-COVID conditions on public health remain. A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment.